Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2026 Filed Oct 9, 2026 16:57 UTC |
Degnan ChrisChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-032421 · rdgdoc.xml · derivative · entry 3 Degnan Chris · CIK 0001741968 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,484 Underlying: Ordinary Shares · 4,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025. F3 · derivative.expiration_date: The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025. Read SEC document |
| October 08, 2026 Filed Oct 9, 2026 16:57 UTC |
Degnan ChrisChief Financial Officer
|
SaleOrdinary Shares | 2,202 | $36.69 | $80,791.38 |
DisclosureSEC source: 0001437749-26-032421 · rdgdoc.xml · nonDerivative · entry 2 Degnan Chris · CIK 0001741968 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,561 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| October 08, 2026 Filed Oct 9, 2026 16:57 UTC |
Degnan ChrisChief Financial Officer
|
Exercise / conversionOrdinary Shares | 4,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-032421 · rdgdoc.xml · nonDerivative · entry 1 Degnan Chris · CIK 0001741968 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 18:37 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 871 | $42.92 | $37,383.32 |
DisclosureSEC source: 0001437749-26-029965 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,882 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 18:35 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,519 | $42.54 | $64,618.26 |
DisclosureSEC source: 0001437749-26-029963 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,141 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| September 07, 2026 Filed Sep 9, 2026 18:37 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-029965 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. Read SEC document |
| September 07, 2026 Filed Sep 9, 2026 18:37 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-029965 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| September 07, 2026 Filed Sep 9, 2026 18:35 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-029963 · rdgdoc.xml · derivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024. Read SEC document |
| September 07, 2026 Filed Sep 9, 2026 18:35 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 3,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-029963 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 16:01 UTC |
Robinson James A. Jr.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-029175 · rdgdoc.xml · derivative · entry 2 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| August 26, 2026 Filed Aug 28, 2026 16:01 UTC |
Robinson James A. Jr.Director
|
Exercise / conversionordinary shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-029175 · rdgdoc.xml · nonDerivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:03 UTC |
Schoenberg MarkChief Medical Officer
|
Saleordinary shares | 60,677 | $47.05 | $2,854,852.85 |
DisclosureSEC source: 0001437749-26-028840 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,086 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $49.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 18:17 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001437749-26-023290 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,763 F1 · kind: Transaction made pursuant to a duly adopted trading plan under Rule 10b5-1(c). The adoption date of the referenced Rule 10b5-1(c) plan is August 15, 2025. This transaction represents the final sale under such trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 and $40.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:22 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 10,000 | $35.01 | $350,100.00 |
DisclosureSEC source: 0001437749-26-021523 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,763 F1 · kind: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 and $35.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 10:01 UTC |
Holden StuartDirector
|
GrantStock Option (right ot buy) · Derivative | 20,000 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001437749-26-021515 · rdgdoc.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:03 UTC |
Wildman Daniel GeorgeDirector
|
GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021519 · rdgdoc.xml · derivative · entry 2 Wildman Daniel George · CIK 0001952679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:03 UTC |
Wildman Daniel GeorgeDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001437749-26-021519 · rdgdoc.xml · derivative · entry 1 Wildman Daniel George · CIK 0001952679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:02 UTC |
Robinson James A. Jr.Director
|
GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021517 · rdgdoc.xml · derivative · entry 2 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:02 UTC |
Robinson James A. Jr.Director
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001437749-26-021517 · rdgdoc.xml · derivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:00 UTC |
BUTITTA CYNTHIA MDirector
|
GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021513 · rdgdoc.xml · derivative · entry 2 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 14:00 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001437749-26-021513 · rdgdoc.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 13:58 UTC |
WEN LEANADirector
|
GrantRestricted Stock Unit · Derivative | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021511 · rdgdoc.xml · derivative · entry 2 WEN LEANA · CIK 0001847598 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Ordinary Shares · 8,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 13:58 UTC |
WEN LEANADirector
|
GrantStock Option (right ot buy) · Derivative | 10,000 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001437749-26-021511 · rdgdoc.xml · derivative · entry 1 WEN LEANA · CIK 0001847598 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 13:57 UTC |
Belldegrun ArieDirector
|
GrantStock Option (right ot buy) · Derivative | 20,000 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001437749-26-021509 · rdgdoc.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 17:59 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-019964 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 17:59 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 5,222 | $27.30 | $142,560.60 |
DisclosureSEC source: 0001437749-26-019964 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,763 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 17:59 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-019964 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| May 26, 2026 Filed May 27, 2026 12:04 UTC |
Robinson James A. Jr.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-018442 · rdgdoc.xml · derivative · entry 2 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Ordinary Shares · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| May 26, 2026 Filed May 27, 2026 12:04 UTC |
Robinson James A. Jr.Director
|
Exercise / conversionordinary shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-018442 · rdgdoc.xml · nonDerivative · entry 1 Robinson James A. Jr. · CIK 0001734295 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| May 08, 2026 Filed May 11, 2026 19:54 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 10,000 | $30.00 | $300,000.00 |
DisclosureSEC source: 0001437749-26-016104 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,985 F1 · kind: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 and $30.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 00:37 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 3,686 | $19.69 | $72,577.34 |
DisclosureSEC source: 0001437749-26-003040 · rdgdoc.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,985 F1 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 00:37 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,843 | $19.69 | $36,288.67 |
DisclosureSEC source: 0001437749-26-003040 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,671 F1 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 00:37 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 1,844 | $19.69 | $36,308.36 |
DisclosureSEC source: 0001437749-26-003040 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,514 F1 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,217 | $19.69 | $63,342.73 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 6 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,588 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,608 | $19.69 | $31,661.52 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 4 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,326 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 2,654 | $19.69 | $52,257.26 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,934 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 7 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. F5 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 6 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 5 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,334 Underlying: Ordinary Shares · 6,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026. F2 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 4 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334 Underlying: Ordinary Shares · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 3,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · nonDerivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 6,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:18 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-002843 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 22:16 UTC |
Degnan ChrisChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 32,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-002841 · rdgdoc.xml · derivative · entry 1 Degnan Chris · CIK 0001741968 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,609 Underlying: Ordinary Shares · 32,609 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. Read SEC document |
| January 31, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 32,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 10 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,609 Underlying: Ordinary Shares · 32,609 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F6 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. F6 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029. Read SEC document |
| January 31, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 6,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 9 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. Read SEC document |
| January 31, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 8 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Ordinary Shares · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 7 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Ordinary Shares · 5,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. F5 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025. Read SEC document |
| January 31, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 6,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 5 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2026 Filed Feb 11, 2026 19:54 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.